Gapping down
In reaction to disappointing earnings/guidance:
- ISRG -5.9%, CTST -5.1%, AXGN -3.6%, STLD -1.2%, GBCI -0.9%
Select China related names showing weakness:
- SFUN -3.7%, WUBA -1.5%, BABA -0.9%, JD -0.9%, BIDU -0.9%
Other news:
- MBIO -9.4% (after soaring more than 100% higher Thursday)
- TSLA -2% (SEC filing discloses that four Board members will step down as part of 'corporate governance initiative'; also co investigating car fire in Shanghai, according to Bloomberg) I -1.9% (Intelsat announced that the anomaly previously disclosed on April 10 has resulted in the total loss of theIntelsat 29e spacecraft)
- LLY -1.7% (Pfizer and Lilly report top-line results from long-term Phase 3 study of tanezumab in patients with osteoarthritis; Patients who received tanezumab 2.5 mg did not experience a statistically significant improvement)
- BA -1.1% (Experts from nine civil aviation authorities have confirmed they will participate in the Boeing 737 MAX Joint Authorities Technical Review)
- PFE -0.7% (Pfizer and Lilly report top-line results from long-term Phase 3 study of tanezumab in patients with osteoarthritis; Patients who received tanezumab 2.5 mg did not experience a statistically significant improvement)
- PRTA -0.7% (reports results from Ph 3 VITAL amyloidosis study of NEOD001 in AL Amyloidosis; post hoc analyses revealed potential survival benefit in category of patients at the highest risk for early mortality)
- STNE -0.6% (after closing 24% lower on Thursday; CEO issues letter to shareholders, says always monitoring our competitive landscape and taking note of various marketing programs)
Analyst comments:
- NI -0.8% (downgraded to Neutral at Citigroup)